You are here

  • Home
  • Archive
  • Volume 80, Issue 10
  • Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

Article metrics

Article menu
XML
Epidemiology
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

 

Online download statistics by month:

Online download statistics by month: March 2021 to February 2023

AbstractFullPdf
Mar 2021743674201442
Apr 202110267101924222
May 20211012499272875
Jun 2021363934381237
Jul 202124232260988
Aug 202148564708856
Sep 202122982178802
Oct 202114211335666
Nov 202111111062530
Dec 2021910879306
Jan 2022700670248
Feb 2022695667236
Mar 2022454436207
Apr 2022459435157
May 2022439432177
Jun 202235334990
Jul 202228827680
Aug 202231229391
Sep 202233131466
Oct 202243140682
Nov 202225624166
Dec 202230729269
Jan 202326122361
Feb 202320818650
Total499794861915604